Zhejiang CONBA Pharmaceutical's cash and EBIT growth point t...

Moomoo AI Dec 8, 2023 16:49

Zhejiang CONBA Pharmaceutical's cash and EBIT growth point to its good position to handle any potential debt. Its strong cash conversion indicates a sturdy financial stance.

Does Zhejiang CONBA PharmaceuticalLtd (SHSE:600572) Have A Healthy Balance Sheet?

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

529 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

3445Followers

0Following

8257Visitors